Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
about
Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain modelRenal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceAssociation of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgeryEpoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition.Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase.Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.T-type calcium channel blocker attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis by activating the Nrf2 antioxidant pathway.Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.Screening of soluble epoxide hydrolase inhibitory ingredients from traditional Chinese medicines for anti-inflammatory use.Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy.Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease.Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability.Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients.
P2860
Q27334040-6F3589FC-B052-4B25-A12E-E0ED13C9F48AQ28395323-D696F47B-CB56-4DB7-9EDD-11DAE478DF92Q28398028-B8F6341C-E40A-427A-AB2F-413481CB2457Q33731887-E7D1281E-DA7F-428F-A88E-FA5B51384DF3Q33854978-5DCDF2ED-9AAB-48EC-9C0F-823B97F5A4C8Q35061561-F2A7BA73-A7E6-4F13-9CC7-763B24B662BAQ35992841-5519F994-CF28-4136-AFC5-8AFE3E152F44Q36535579-6DC1757C-C6D4-4994-B58E-D382A3B97522Q37448061-B6307303-30B2-44F7-A65C-67E5D09E638CQ38605323-DBF01EC0-BAD1-4056-941E-134DF58F8F29Q39644067-7AD4C653-4AEB-4C2F-A1CD-4D123CD2609BQ45990632-10660359-6EBE-4290-B13E-85BC26CFAA1BQ46171557-EC3EE454-CE6C-400F-9105-38E0565E188BQ47143230-92DCF546-D67F-49DD-9E00-230AB2861964Q47148741-151203B8-78AE-47E1-BBE4-6694D7530ED2Q47702795-53BB207D-11A1-40AD-B147-9F7D09612BCBQ50326733-48CBC18E-8CA5-477C-87DA-0FF72060344BQ52642084-D563F9B0-D6FE-4121-8BDA-BB45B06E3CFEQ52674866-EFEA0A97-CB08-4B46-9361-1FC7938FD491Q55248474-2E92D36E-6F87-42C8-BFB3-6FC20CA17BB0
P2860
Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological inhibition of ...... is in obstructive nephropathy.
@ast
Pharmacological inhibition of ...... is in obstructive nephropathy.
@en
type
label
Pharmacological inhibition of ...... is in obstructive nephropathy.
@ast
Pharmacological inhibition of ...... is in obstructive nephropathy.
@en
prefLabel
Pharmacological inhibition of ...... is in obstructive nephropathy.
@ast
Pharmacological inhibition of ...... is in obstructive nephropathy.
@en
P2093
P2860
P1476
Pharmacological inhibition of ...... sis in obstructive nephropathy
@en
P2093
Babu J Padanilam
Bruce D Hammock
Myron L Toews
Sang Pil Yoon
Sung Hee Hwang
P2860
P304
P356
10.1152/AJPRENAL.00531.2014
P577
2014-11-05T00:00:00Z